ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2378

Is Urinary Protein-creatinine Relation Reliable for Diagnosis or Follow up of Lupus Nephritis?

Ana Clara Freitas Ribeiro1, Evandro Klumb1, Rafaela Gonçalves Rodrigues2, Ramiro Camacho Junior2, Flavia Bastos2, Mariel Lizarralde1, Raissa de Oliveira1 and Ricardo Aguiar Filho1, 1Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2Rio de Janeiro State University, Rio de Janeiro, Brazil

Meeting: ACR Convergence 2024

Keywords: Lupus nephritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 18, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Lupus nephritis (LN) is a highly morbid condition with a pleomorphic presentation and fluctuating activity. Proteinuria is a typical manifestation of renal involvement, crucial for LN diagnosis, guiding renal biopsy and inferring histological class. It serves as a biomarker for therapeutic response and a prognostic indicator for renal function preservation

The protein-creatinine Ratio (PCR) is a widely used method to estimate the amount of total proteinuria using a urine sample, being used as a substitute for the 24-hour urine collection.

There are no recent reviews suggesting that the 24-hour urine collection for protein measurement should be universally preferred over the PCR from a urine sample. Both methods have their advantages and limitations.

Methods: Urine samples were collected from all patients over 24 hours, and also at four pre-established time points – noon (S1), 6pm (S2), midnight (S3), and 6am (S4) during the same period. PCR measurements were obtained in each of the samples, and then compared to the 24-hour urine volume using Pearson correlation coefficient. PCR values variation was also calculated among all patients at each time point and for each patient across different samples.

Results: When comparing the 24-hour urine proteinuria values with the PCR at each time point a strong correlation in the mean values of the measurements was noted, with p-values of 0.801 for S1, 0.836 for S2, 0.801 for S3, and 0.859 for S4.

Regardless the strong correlation, a significant variation among the time points was observed, giving a variation range (compared to the 24h proteinuria) of -58,33% to 126,42% for S1, -52,73% to 56,12% for S2, -47,37% to 116,02% for S3 and -61,45% to 70,74% to S4 (picture 1), with a mean value ranging from -33,77% to 33,09% for S1, -29,32% to 29,38% for S2, -27,89% to 38,44% for S3, -24,07% to 27,69% for S4 (picture 2). The smallest variation was observed in S2. The variation of each patient for each sample is shown in picture 3 (each color represents a patient).

Conclusion: The strong correlation (r≈0.8) between mean PCR values at each time point and the 24-hour sample does not accurately represent individual proteinuria. PCR estimates could be significantly higher (+126.42%) or lower (-61.45%) than the 24-hour proteinuria. These data suggest that multiple PCR urine samples may reduce variation for a specific patient, but 24-hour urine collection remains a more accurate proteinuria evaluation.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: A. Freitas Ribeiro: None; E. Klumb: None; R. Gonçalves Rodrigues: None; R. Camacho Junior: None; F. Bastos: None; M. Lizarralde: None; R. de Oliveira: None; R. Aguiar Filho: None.

To cite this abstract in AMA style:

Freitas Ribeiro A, Klumb E, Gonçalves Rodrigues R, Camacho Junior R, Bastos F, Lizarralde M, de Oliveira R, Aguiar Filho R. Is Urinary Protein-creatinine Relation Reliable for Diagnosis or Follow up of Lupus Nephritis? [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/is-urinary-protein-creatinine-relation-reliable-for-diagnosis-or-follow-up-of-lupus-nephritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-urinary-protein-creatinine-relation-reliable-for-diagnosis-or-follow-up-of-lupus-nephritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology